ReviewEuropean journal of immunology2021
Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection.
Farzan Solimani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this paperpooled ittrialcites it